Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study

Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression may respond to enzalutamide with greater response association in higher levels. A metr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elwan, Amira, Abdelrahman, Aziza E., Alnagar, Ahmed A., Abdelhamid, Mohamed I, Nawar, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federation of Turkish Pathology Societies 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512684/
https://www.ncbi.nlm.nih.gov/pubmed/33432555
http://dx.doi.org/10.5146/tjpath.2020.01516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512684/
https://www.ncbi.nlm.nih.gov/pubmed/33432555
http://dx.doi.org/10.5146/tjpath.2020.01516

Ejemplares similares